Published in Cancer Weekly, April 20th, 2004
The data were presented March 28, 2004, at the 95th Annual Meeting of the American Association for Cancer Research.
"We have found that the overexpression of COX-2 correlates with the loss of the basement membrane in ovarian epithelium cells, thus promoting cancer," reported Mike (Xiang-Xi) Xu, PhD, who heads the Fox Chase team in this research. "A COX-2 inhibitor may reduce the loss of basement membrane and thus...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.